Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,307 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05603715RecruitingPhase 2
Pyridostigmine to help constipation in Parkinson’s
This trial tests whether pyridostigmine can improve constipation symptoms in people with Parkinson’s disease. If you have Parkinson’s and functional constipation (with infrequent bowel movements), this study may offer a new medication option and closely track your bowel function.
Burlington, VermontAges 18 years+ - NCT05619185Recruiting
Online program to help couples reduce risky drinking
This study tests an adaptive (tailored) online program to help service members and their partners cut down risky alcohol use. It also focuses on whether couples can practice healthier communication and coping skills while feeling safe together.
Palo Alto, CaliforniaAges 18 years+ - NCT05597488Recruiting
Measuring pressure to predict varice treatment response
This study checks whether a special ultrasound-guided measurement of blood pressure in your liver can help predict how well endoscopic treatment (banding varices or injecting bleeding sites) will work. It aims to improve outcomes by identifying who is more likely to respond.
Hong Kong, Hong KongAges 18–75 - NCT05613153Enrolling by invitation
Peppermint oil for children with bladder and bowel problems
This trial tests whether peppermint oil can improve bladder and bowel control problems in children who did not get better with behavior-based treatment. If it works, it may reduce symptoms and improve daily bathroom habits.
Orange, CaliforniaAges 8–17 - NCT05624996RecruitingPhase 3
Targeted high-dose radiation added to standard lung cancer treatment
This trial tests whether adding high-dose, targeted radiation to the usual treatment helps people with locally advanced, non-operable lung cancer live longer or better control the cancer. It may help shrink tumors in the chest and improve outcomes when surgery can’t be done.
Birmingham, AlabamaAges 18 years+ - NCT05626920RecruitingPhase 1/Phase 2
Disulfiram trial for inherited vision loss in one eye
This early-stage study tests whether disulfiram can help preserve vision in people with inherited retinal degeneration. It focuses on one study eye and uses strict eye, blood/liver, and alcohol-avoidance rules because the medicine can affect the body and needs careful safety monitoring.
Seattle, WashingtonAges 18 years+ - NCT05627674Enrolling by invitation
Help improve lung cancer screening and quitting support uptake
This study tests a “precision” approach to help people who are newly eligible for lung cancer screening actually get screened and start smoking-cessation treatment. If it works, it could make screening and quitting help easier to access and more engaging.
St Louis, MissouriAges 18 years+ - NCT05620719Recruiting
Study delayed headache after head injury in veterans
This study looks at treatment for ongoing headache that starts or gets worse after a mild or moderate head/neck injury in veterans or active-duty service members. It may help by testing an approach aimed at reducing headache burden and improving daily functioning.
Los Angeles, CaliforniaAges 18–70 - NCT04841447Recruiting
Testing a blood-membrane target to treat leukemia
This study looks for a specific marker on leukemia cells and uses it to guide treatment. If you qualify, your care team will check whether this target can be detected and used to help treat your leukemia.
Columbia, MissouriAges 18 years+ - NCT05561387RecruitingPhase 3
Drug combinations for newly diagnosed myeloma without transplant
This study compares different combinations of medicines for people newly diagnosed with multiple myeloma who cannot safely get a stem cell transplant. It aims to find which drug plan works best and is tolerable for people with “frail” or “intermediate fit” health.
Anchorage, AlaskaAges Any age - NCT05554393RecruitingPhase 2
Treating intermediate-risk AML in younger adults
This trial compares three different drug combinations for younger adults (18-59) with intermediate-risk AML. You will be assigned to one of three groups: standard chemotherapy (cytarabine + daunorubicin), that same chemotherapy plus venetoclax, or venetoclax combined with azacitidine.
Birmingham, AlabamaAges 18–59 - NCT05584124RecruitingPhase 2
Brain stimulation to treat fatigue after stroke
This study tests a non-invasive brain stimulation treatment called repetitive transcranial magnetic stimulation (rTMS) to see if it can reduce fatigue after a stroke. If you have ongoing tiredness that started or got worse after your stroke, this treatment might help.
Decatur, GeorgiaAges 34–80 - NCT05588453RecruitingPhase 1/Phase 2
Immunotherapy and temozolomide for melanoma brain metastases
This early-phase study tests an immune cell treatment (natural killer cells) plus temozolomide to treat melanoma that has spread to the brain. It’s for people whose brain spots are getting worse and who are not good candidates for certain types of brain radiation.
Columbus, OhioAges 18 years+ - NCT05584046Recruiting
Herbal patch for heel pain
This trial tests a new herbal patch for treating heel pain (plantar fasciitis). The patch is applied to the skin, and the study aims to see if it helps reduce pain.
ShatinAges 18–70 - NCT05591040Recruiting
Biofeedback to help swallow problems after stroke
This trial studies whether using “biofeedback” (seeing your body’s muscle signals on a screen) along with standard care can improve swallowing after a stroke. You might be eligible if you have ongoing swallow trouble and can safely do the training sessions.
Venice-LidoAges 18–89 - NCT05554172Recruiting
Non-invasive vagus nerve stimulation during refeeding for low weight
This study tests whether a painless device that stimulates the vagus nerve can help teens who are underweight and working on refeeding (a structured nutrition plan). It aims to see if this treatment improves outcomes while you’re gaining weight.
New York, New YorkAges 14–22 - NCT05561907Recruiting
Endoscopic vs. surgical bypass for stomach blockage from cancer
This trial compares two ways to bypass a blockage in your stomach caused by cancer near the pancreas or duodenum. Both approaches create a new connection so food can pass through, but one uses a camera-guided tube (endoscopic) and the other is surgical. The study will see which works better for your symptoms and quality of life.
New Brunswick, New JerseyAges 18 years+ - NCT05582837RecruitingPhase 4
Using migraine medicines to treat Meniere’s disease symptoms
This Phase 4 study tests whether migraine-type medications can help people with active or frequent Meniere’s disease. If you have symptoms like inner-ear episodes, the trial may help find a better way to control them.
Orange, CaliforniaAges 25–85 - NCT05576389RecruitingPhase 2
Fluzoparib plus camrelizumab before surgery for BRCA-related HER2-negative breast cancer
This study tests a combination of two drugs – fluzoparib (a PARP inhibitor) and camrelizumab (an immunotherapy) – given before surgery for early-stage or locally advanced HER2-negative breast cancer in people with an inherited BRCA mutation. The goal is to see if this treatment can shrink the tumor and improve outcomes.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05562258Recruiting
Peer coaching for teens with eating disorders
This study tests a “peer-coaching” program where a teen receives support from someone with lived experience, alongside their care. It may help improve how teens manage their eating disorder treatment and feel supported during recovery.
New York, New YorkAges 12–18 - NCT05555485Recruiting
Check if ear stimulation can help chronic pain and reduce opioids
This study tests whether a device that stimulates the ear (through the skin) can reduce chronic pain and help people lower their opioid pain medicine. It may help you manage pain with less opioid use if you meet their safety and medication criteria.
Galveston, TexasAges 18–65 - NCT05559853Recruiting
MRI scan study to track brain tumor changes after treatment
This study tests a new MRI (brain scan) method to see how brain tumors change over time after treatment. There are also parts for healthy adults to help with developing and comparing the scan technique.
New York, New YorkAges 18 years+ - NCT05584007RecruitingPhase 3
Choosing the best antibiotic length for leg cellulitis
This Phase 3 study compares 5 days versus 7 days of antibiotic treatment for new leg cellulitis (skin infection). It may help you get the right treatment duration while keeping side effects and recovery in mind.
SouthamptonAges 18 years+ - NCT05567640Recruiting
Smart digital mental health support
This study tests a digital mental health program that uses smart technology to personalize your experience and keep you engaged. If you join, you may get a more tailored approach to improving your mental well-being.
Boston, MassachusettsAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,307 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.